Nifekalant Hydrochloride
盐酸尼非卡兰
Report date: 2023/03/03 09:37:30
NME
Base Information
Drug NameNifekalant Hydrochloride
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1999/09/09
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesToa Eiyo Ltd
China Registration ClassN/A
Develop Information
Active CompaniesToa Eiyo LtdSichuan Baili Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications